. 2024 Apr 4;11(5):1338–1346. doi: 10.1002/acn3.52051
© 2024 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Figure 4.
Questionnaire of preferences between eculizumab and ravulizumab.